Critical evidence is generated continuously across sites, CROs, vendors, systems, documents and workflows, but it is often fragmented, reviewed in isolation and understood only after manual reconciliation or escalation.
That creates decision latency — the gap between something beginning to change in the trial, its significance being recognised, and action being taken.
Most clinical systems are designed to capture, manage and report information within their own domain. They are not designed to interpret evidence across the wider trial, apply protocol, SOP, regulatory and operational logic in context, or surface emerging risk as it develops.
